Document is current

Article History

Received: 1 February 2019

Accepted: 18 March 2019

First Online: 28 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Drs. Zuercher, Moret, and Schefold declare that the Department of Intensive Care Medicine, Inselspital, Bern, has received research or other grants from (full disclosure) Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd., Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, and Nycomed outside the submitted work. The money was paid into departmental funds. No personal financial gain applies. Dr. Dziewas declares no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.